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https://doi.org/10.1016/j.stemcr.2018.04.016SUMMARYUnderstanding the molecular pathways controlling hematopoietic stem cell specification and expansion is a necessary milestone to
perform regenerative medicine. Here, we used the zebrafish model to study the role of the ckit signaling pathway in this process. We
show the importance of kitb/kitlgb signaling in the specification and expansion of hematopoietic stem cells (HSCs), in the hemogenic
endothelium and caudal hematopoietic tissue (CHT), respectively. Moreover, we identified the zebrafish ortholog of Oncostatin M
(osm) in the zebrafish genome. We show that the osm/osmr pathway acts upstream of kitb during specification of the hemogenic
endothelium, while both pathways act synergistically to expand HSCs in the CHT. Moreover, we found that osm, in addition to its
role in promotingHSC proliferation, inhibits HSC commitment to the lymphoid fate. Altogether, our data identified two cytokines, kitlgb
and osm, secreted by the vascular niche, that control HSCs during early embryonic development.INTRODUCTION
Hematopoietic stem cells (HSCs) are multipotent progeni-
tors that sustain blood production from embryonic devel-
opment to adulthood. Currently, ex vivo HSC expansion
and HSC generation from induced pluripotent stem cells
are the limiting factors toward achieving personalized
cell-based regenerative medicine, creating a need to fully
understand the signaling pathways involved in these
processes. Definitive hematopoiesis development is very
conserved in vertebrates. In both zebrafish and mammals,
after primitive hematopoiesis has emerged, definitive
hematopoiesis occurs in two waves: first, transient er-
ythro-myeloid precursors (EMPs) arise in the yolk sac and
posterior blood island, from mice (Bertrand et al., 2005)
and zebrafish (Bertrand et al., 2007), respectively. Then,
HSCs are specified from the aortic hemogenic endothelium.
In the mouse embryo, HSC specification occurs along the
ventral aspect of large arteries, predominantly in the
aorta-gonads-mesonephros (AGM) region (Boisset et al.,
2010;Chenet al., 2009; Zovein et al., 2008) between embry-
onic (E) day 9.5 and 11.5. In the zebrafish, HSCs are born at
32–60 hr post fertilization (hpf), from the hemogenic endo-
thelium located in the dorsal aorta (Bertrand et al., 2010;
Kissa and Herbomel, 2010). As the embryo makes a limited
number ofHSCs, theymigrate to a first niche thatwill allow
their expansion. In mouse, this initial expansion occurs in
the fetal liver (Ema andNakauchi, 2000), whereas zebrafish
HSCs colonize the caudal hematopoietic tissue (CHT) (Tam-
plin et al., 2015). In bothmodels, HSCs interact with endo-
thelial cells (ECs) that promote their proliferation (Khan
et al., 2016; Tamplin et al., 2015). We, and others, have
shown that this expansion depends on several cytokines1920 Stem Cell Reports j Vol. 10 j 1920–1934 j June 5, 2018 j ª 2018 The A
This is an open access article under the CC BY-NC-ND license (http://creativproduced by stromal cells and caudal ECs (cECs) (Mahony
et al., 2016; Tamplin et al., 2015).
Many studies performed in the mouse model demon-
strated the importance of the cKit/KitL pathway in HSC
maintenance in vivo, or HSC expansion ex vivo (Ding
et al., 2012; Oostendorp et al., 2008). However, little is
known about the role ofKit signaling during the emergence
of definitive hematopoiesis in themouse embryo. In zebra-
fish, the role of kit in hematopoiesis still remains unclear.
The zebrafish genome encodes two paralogs, kita and kitb,
following genome duplication and possible sub-function-
alization (Mellgren and Johnson, 2005). Kita, but not kitb,
is important for pigmentation and melanocyte develop-
ment (Hultman et al., 2007) and appears not to be required
for hematopoiesis, as adult sparse mutants (kita/) show
normal adult hematopoiesis (Parichy et al., 1999). Simi-
larly, there are two paralogs for the stem cell factor (kit-
ligand): kitlga is important for melanocyte normal develop-
ment and, interestingly, kitlgb is expressed in the posterior
blood island at 24 hpf (Hultman et al., 2007), strongly sug-
gesting a role for this gene in zebrafish hematopoiesis.
Furthermore, we recently showed that kitlgb could rescue
the loss of HSCs observed in tfec mutants (Mahony et al.,
2016). KITL also plays a major role in the expansion of
human HSCs ex vivo but always in conjunction with other
cytokines. Current clinical protocols targeting human
HSCs for gene therapies usually use a cytokine cocktail
composed of KITL, FLT3L, and TPO (Cavazzana-Calvo
et al., 2000; Petzer et al., 1996; Ribeil et al., 2017). However,
other cytokines seem to be potent to expand HSCs, such as
human Oncostatin M (OSM). Oostendorp and colleagues
showed that KITL together with OSM, but not by itself,
could promote the expansion of immature human cord-uthor(s).
ecommons.org/licenses/by-nc-nd/4.0/).
blood HSPCs and improve repopulating activity in NOD/
SCID mice (Oostendorp et al., 2008). OSM mediated these
effects by downregulating the KITL-induced MAPK/ERK
pathway to preserve high CD34 expression (Oostendorp
et al., 2008). This was further corroborated by studies
showing that AGM hematopoiesis was enhanced in vitro
bymedia containing amix of KIT,OSM, LIF, and FGF (Nish-
ikawa et al., 2001).
OSM is a cytokine belonging to the IL-6 family and has
pleiotropic actions in hematopoiesis, inflammation, and
neural development (Mukouyama et al., 1998; Rose et al.,
1994; Tanaka and Miyajima, 2003). Osm binds a hetero-
dimer that combines the OSM receptor chain (OSMR) and
the signaling gp130 chain, which induces the intracellular
activation of the JAK/STATandMAPK pathways (Dey et al.,
2013).OSM is expressed in a range of hematopoietic tissues,
including thymus, bone marrow (BM), and spleen, and
plays a role in the maintenance of hematopoietic
progenitors through cell and non-cell autonomousmecha-
nisms (Sato et al., 2014; Tamura et al., 2002; Tanaka et al.,
2003). BM transplantation studies have shown that BM
fromwild-type (WT)mice transplanted intoOsmr-deficient
mice results in reduced erythrocytic/megakaryocytic pro-
genitors. The same effect is observed when BM from
Osmr-deficient mice is transplanted into WT mice (Tanaka
et al., 2003). In contrast, ectopic overexpression of Osm
resulted in enhanced extra-medullary hematopoiesis and
increased megakaryocyte and platelet production (Wallace
et al., 1995). Moreover, Osm-deficient mice show a reduced
thymus size as well as an accumulation of apoptotic thy-
mocytes, suggesting that a fine balance of Osm signaling
is required for correct thymocyte development (Esashi
et al., 2009).
In this study, we show that kitb/kitlgb, but not kita/kitlga,
is required for HSC specification, emergence, and expan-
sion in the CHT. We also identified the zebrafish ortholog
osm, and characterized the function of this cytokine
in zebrafish hematopoiesis. By combining different ap-
proaches, we show that zebrafish osm retains similar func-
tion to its mammalian ortholog and can expand HSCs, but
also inhibits lymphoid commitment. We also show that
interfering with osmr results in an early block in the speci-
fication of the hemogenic endothelium. Finally, we show
that osm and kitlgb synergistically enhance HSC prolifera-
tion and decrease HSC differentiation.RESULTS
Kitb, but Not kita, Signaling Is Necessary for HSC
Specification
To understand the roles of kita and kitb in zebrafish HSC
biology, we examined their expression during definitivehematopoiesis. In fluorescence-activated cell sorting
(FACS)-sorted hematopoietic progenitors (EMPs and
HSCs), we found that kita was mildly enriched in HSCs
but found a much higher enrichment of kitb in both
EMPs and HSCs (Figure 1A), although HSC enrichment
was not significant compared with the whole embryo (Fig-
ure 1A). To further study these signaling pathways, we in-
jected full-length mRNA for kitlga or kitlgb and knocked
down the expression of kita and kitb using morpholinos
(Figures S1A–S1D). The injection of kitlga and kitlgb
mRNA did not alter cmyb expression at 4 days post fertiliza-
tion (dpf) (Figure 1B). However, kitb morphants showed
reduced cmyb expression at 4 dpf (Figure 1B) and reduced
rag1 expression at 4.5 dpf (Figure S1G). This loss of cmyb
signal (i.e., loss of HSPCs in the CHT) likely resulted from
a defect in HSC specification in kitb morphants, as shown
by reduced levels of runx1 and cmyb along the aorta at 28
and 36 hpf, respectively (Figure 1C). However, gata2b
expression at 22 hpf was maintained in kitb morphants,
indicating that specification of the hemogenic endothe-
lium is not dependent on kitb signaling (Figure 1C). In
contrast, the expression of gata2b at 22 hpf, runx1 at
28 hpf, and cmyb at 36 hpf was normal in kita morphants
(Figure 1C). The hematopoietic phenotype observed in
kitb morphants was identical in kiltgb morphants (Figures
1D, S1E, and S1F). Both kita and kitb morphants displayed
normal primitive myelopoiesis as detected by mfap4
(primitive macrophages) and mpx (primitive neutrophils)
expression (Figure S1H). Some kitb morphants had a
modest reduction in primitive erythrocytes (Figure S1H)
and some showed disrupted vasculature development
(n = 5/12, data not shown). We also confirmed that kitlga
mRNA injection resulted in hyper-pigmentation, while
kitamorphants had a reduction in the number of melano-
cytes over the yolk ball (Figures S1I–S1K), in agreement
with previous studies (Hultman et al., 2007). In contrast,
embryos injected with either kitlgb mRNA or the kitb mor-
pholino showed no alteration of their pigmentation
pattern (Figures S1I–S1K). We therefore conclude that
kita/kitlga signaling is not required for definitive hemato-
poiesis but only for melanocyte development as previously
suggested. We also conclude that kitb/kitlgb signaling is
required for proper HSC specification, likely at the cell
autonomous level, but one cannot exclude a non-cell
autonomous mechanism, as a consequence of our qPCR
data. Moreover, kitlgb gain of function by itself cannot in-
crease HSC expansion, as we previously observed (Mahony
et al., 2016). Therefore, we looked for a cytokine that could
interact with kitlgb to promote HSC expansion.
Identification of Zebrafish osm
Based on previous human studies, wewanted to investigate
the synergy between osm and kitlgb (Oostendorp et al.,Stem Cell Reports j Vol. 10 j 1920–1934 j June 5, 2018 1921
Figure 1. kitb, but Not kita, Signaling Is Necessary for Correct HSC Specification
(A) qPCR expression of kita and kitb in FACS-sorted hematopoietic progenitors. Kita whole and EMPS, p = 0.14. kita whole and HSCs,
p < 0.0001. kitb whole and EMPs, p = 0.023. kitb whole and HSCs, p = 0.14. EMPs: double-positive lmo2:eGFP, gata1:DsRed cells (28 hpf)
(Bertrand et al., 2007). HSCs: double-positive flk1:mCherry, cmyb:eGFP cells (36 hpf) (Bertrand et al., 2010). Data are from biological
triplicates. Data are means ± SD.
(B) cmyb ISH at 4dpf in non-injected control (NI), kitlga (injected at 500 pg throughout, unless stated) or kitlgb (injected at 200 pg
throughout, unless stated) mRNA injected embryos. cmyb was socred at 4dpf following ctrl-MO, kita-MO (injectedat 3 ng throughout,
unless stated) or kitb-MO (injected at 8 ng throughout, unless stated) injection. NI, non-injected control. +kitlga/kitlgb, kitlga/kitlgb full
length mRNA injected embryos.
(C) Control-MO, kita-MO and kitb-MO injected embryos were scored for the expression of gata2b, runx1 and cmyb at 22 hpf, 28 hpf and 36
hpf, respectively. (D) kitlgb morphants were scored for gata2b, runx1 and cmyb at 22 hpf, 28 hpf and 4 dpf, respectively. Analysis was
completed using ordinary one way ANOVA with multiple comparisons. **** p < 0.0001; *p < 0.05; NS, p > 0.05. All scale bars, 100 mm.
1922 Stem Cell Reports j Vol. 10 j 1920–1934 j June 5, 2018
Figure 2. osm Expands HSCs within the CHT Niche
(A and A0) Experimental outline and qPCR expression of osm from whole zebrafish or FACS-sorted ECs. Data are biological triplicates plated
in technical duplicates.
(legend continued on next page)
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2008). However, no ortholog was annotated in the zebra-
fish genome. To identify osm, we proceeded by synteny
analysis. The mouse and human OSM orthologs both lie
in close proximity to Gatsl and GATSL3, respectively. In
the zebrafish genome, we found a homologous transcript
lying in close proximity to gatsl3 (Figure S2A). This gene,
annotated si:ch73-47f2.1, encodes a protein that segregates
with the mouse and human OSM by phylogeny analysis
but not with the other cytokines tested (Figure S2B).
Furthermore, whenwe compared the gene structures of hu-
man OSM, mouse Osm, and zebrafish si:ch73-47f2.1, we
found a similar arrangement consisting of three exons (Fig-
ure S2C). Amino acid similaritywas low (26.3%withmouse
Osm, 24.7% with human OSM, using EMBOSS Needle), but
this has been previously noted in the characterization of
other zebrafish cytokines when compared with their
mammalian orthologs, such as epo, which shows 32% iden-
tity and 50% similarity between zebrafish and humans
(Chu et al., 2007). Finally, si:ch73-47f2.1 encodes a protein
that contains a four-helical cytokine-like domain that is
highly conservedwith themouse and human proteins (Fig-
ure S2D). We therefore conclude that si:ch73-47f2.1 could
be the zebrafish ortholog of the mammalian OSM. To
further explore this hypothesis we examined the expres-
sion of si:ch73-47f2.1/osm and its receptor (osmr) and
then examined their function during HSC ontogeny.
As the expression of osm was not detectable by in situ
hybridization (ISH) (data not shown), we isolated cECs by
FACS and performed qPCR. We found an enrichment of
osm in the CHT vasculature compared with vasculature
sorted from the rest of the embryo (Figures 2A and A0).
Furthermore, osmr seemed highly enriched in definitive
hematopoietic progenitors, EMPs and HSCs, compared
with the whole embryo even if statistical significance was
not reached (Figure 2B). In contrast, gp130 was expressed
rather ubiquitously (Figure 2C). Therefore, in zebrafish, as
in mammals, the expression of osm and its receptor
strongly correlates with a role in hematopoiesis. We next
investigated the roles of this pathway in zebrafish HSCs.(B and C) qPCR expression of osm, osmr, and gp130 (il6st in zebrafish)
and HSCs). All qPCR data are from biological triplicates. In (A0), (B),
comparisons. In (A0), whole and heads, p = 0.16; whole and tails, p = 0
whole and HSCs, p = 0.14. In (C), whole and EMPs, p = 0.22; whole a
(D and E) ISH expression of cmyb, flk1, and runx1 following injection
unless otherwise stated) or in non-injected embryos. Scale bar, 100 m
(F) Imaging area.
(G and G0) Imaging double transgenic flk1:mCherry/cmyb:GFP embryo
niche. Scale bar, 100 mm. In (G0), between NI and osm injected at 3
(H) Imaging area.
(I and I0) anti-GFP and pH3 immunofluorescence at 3 dpf in cmyb:eGFP
bar, 25 mm. Analysis was performed by an unpaired, two-tailed Stud
control. +osm, osm full-length mRNA-injected embryos. All data are m
1924 Stem Cell Reports j Vol. 10 j 1920–1934 j June 5, 2018osm Signaling Is Sufficient to Expand HSCs
Previous studies have reported that human OSM is capable
of expanding human HSCs while inhibiting lymphoid dif-
ferentiation (Kinoshita et al., 2001; Oostendorp et al.,
2008). When we overexpressed osm by mRNA injection,
we found a consistent increase in cmyb expression in the
CHT compared with non-injected controls at 4 dpf (Fig-
ure 2D). osm mRNA injection did not change runx1 or
flk1 expression at 26 hpf, and therefore did not increase
HSC specification (Figure 2E). We then focused on HSCs
within the niche using flk1:mCherry;cmyb:eGFP double
transgenic embryos (Mahony et al., 2016; Tamplin et al.,
2015) and found an increase in the number of HSCs within
the niche at 3 dpf after osm gain of function compared with
non-injected control embryos (Figures 2F–2G0). By 4 dpf,
this increase was minimal and was close to control levels
(Figures 2F–2G0). We then used cmyb:GFP embryos and
stained for GFP and phospho-histone 3 (pH3), a marker
of cell division, by immunofluorescence. Embryos injected
with osm mRNA exhibited a significant increase in the
number of proliferating HSCs within the CHTat 3 dpf (Fig-
ure 2H–2I0). Therefore, we conclude that the osm signaling
pathway expands HSCs within the CHT by augmenting
their proliferation, a result that was very similar to our pre-
vious work where we overexpressed tfec mRNA (Mahony
et al., 2016). Accordingly, we found that osm expression
was augmented in cECs after tfec overexpression (Fig-
ure S3A). Furthermore, osm overexpression could rescue
the loss of cmyb expression observed in tfec mutants (Fig-
ures S3B and S3B0), supporting our conclusion that osm
plays a role in expanding HSCs within the niche. We
next examined the effect of osm on HSC differentiation.
osm Inhibits Lymphocyte Differentiation by Reducing
Lymphoid Gene Expression
Previous studies showed thatOSM suppresses commitment
to the lymphoid fate (Kinoshita et al., 2001). We observed
that osm mRNA injection decreased the thymus size at
4.5 dpf, indicating a decrease in HSC differentiation toin whole zebrafish or FACS-sorted hematopoietic progenitors (EMPs
and (C), analysis was performed by a one-way ANOVA with multiple
.0004; heads and tails, p = 0.0019. In (B), whole and EMPs, p = 0.17;
nd HSCs, p = 0.98.
of full-length osm mRNA (injected at 300 pg here and throughout,
m.
s at 3 and 4 dpf. Arrowheads represent HSCs embedded in the CHT
dpf, p = 0.0097, and at 4 dpf, p = 0.4894.
embryos. Arrows represent double-positive, proliferating cells. Scale
ent’s t test in (G0) and (I0). In (I0), p = 0.0050. NI, non-injected
eans ± SD ***p < 0.001, **p < 0.01, NS, p > 0.05.
AB
C
D
F
E
G H I
(legend on next page)
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the T cell lineage (Figure 3A). To further examine this, we
took advantage of the ikaros:eGFP transgenic line that
marks lymphoid precursors (Hess and Boehm, 2012). First,
we found a decreased number of lymphoid progenitors in
the thymus in osm-injected embryos at 4.5 dpf (Figure S4A),
suggesting a defect in thymic colonization. To understand
this decrease, we examined the CHT of embryos at 48 hpf
when lymphoid precursors are just beginning to seed the
thymus (Murayama et al., 2006). At this stage, there is a
distinct GFPhigh population and many, more difficult to
define GFPlow cells within the CHT. Injection of osm
mRNA resulted in a severe decrease in the number of
GFPhigh cells at 48 hpf in the CHT (Figures 3B and 3C) prob-
ably resulting in the defect of thymic colonization
observed at 4.5 dpf (Figure S4A). To further characterize
the ikaros:GFPhigh and GFPlow populations, we sorted these
subsets from isolated tails dissected from control ikaro-
s:eGFP embryos. We then investigated their gene expres-
sion pattern by qPCR (Figures S4B). Ikaros-GFPhigh cells ex-
pressed high levels of gata3, cmyb, ccr9a, and irf4a. We
therefore defined these cells as lymphoid-primed or
lymphoid-committed HSCs (Figures S4C–S4P), according
to previous results showing that irf4a is required for
lymphoid commitment (Wang et al., 2015). Interestingly,
both populations expressed high levels of kitb and osmr
(Figures S4O and S4P).
To understand the defect in thymic hematopoiesis, we
FACS sorted GFPhigh cells from non-injected or osm
mRNA-injected ikaros:eGFP embryos and measured, by
qPCR, the expression levels of lymphoid genes (Figure 3D).
First, in embryos injected with osm mRNA, we found a
decrease in the percentage of GFPhigh cells suggesting that
osm inhibits HSC differentiation toward the lymphoid line-
age (Figure 3E), concordant with our microscopy observa-
tions (Figure 3B). Second, we saw a decrease in the expres-
sion of il7r, ccr9a, and irf4a (although the decrease in ccr9a
was not significant) (Figures 3F–3I), three important tran-
scripts for T lymphopoiesis, but no change in gata3,
cmyb, or runx1, three genes normally expressed in HSCs
(Figures S3C and S3D). Therefore, osm not only expandsFigure 3. osm Inhibits Lymphocyte Priming and Differentiation b
(A) ISH at 4.5 dpf of rag1 thymus staining with quantification of thy
(B) Live imaging of CHT region in ikaros:eGFP embryos at 48 hpf. Eac
(C) Quantification of the number of ikaros:eGFPhigh cells at 48 hpf, p
(D) FACS sorting and analysis of ikaros:eGFPhigh cells at 48 hpf (p = 0.
means ± SD.
(E) Quantification of ikaros:eGFPhigh cells.
(F–I) qPCR analysis of il7r (F) (p = 0.0017), irf4a (G) (p = 0.0001),
ikaros:eGFPhigh cells FACS sorted at 48 hpf. qPCR data shown are the m
experiments. Each separate experiment was conducted in biological
control. +osm, osm full-length mRNA-injected embryos. Statistical ana
***p < 0.001; **p < 0.01; *p < 0.05; NS, p > 0.05.
1926 Stem Cell Reports j Vol. 10 j 1920–1934 j June 5, 2018HSCs but also inhibits their differentiation toward the
lymphoid lineage by reducing the expression of several
lymphoid receptors and transcription factors necessary
for migration to and maturation in the thymus. Of note,
the decrease in the number of ikaroshigh cells in the CHT
(Figures 3B and 3C) might have an additional explanation
as it is also possible that osm acts directly upon the
lymphoid-committed T cell progenitors that arise directly
from the hemogenic endothelium (Tian et al., 2017).
However, osm overexpression did not alter definitive eryth-
ropoiesis and granulopoiesis (Figure S3E–S3G), but the
number of macrophages was slightly reduced (Figure S3F)
in the CHT. We next inhibited osmr signaling to fully
define the role of this signaling pathway in zebrafish
hematopoiesis.
osmr Signaling Is Necessary for Early HSC
Specification
During mouse embryogenesis, Osm is important for HSC
emergence andmay act at the level of the hemogenic endo-
thelium (Mukouyama et al., 1998). Osm is also required for
adult erythrocyte and megakaryocyte differentiation
(Tanaka et al., 2003). We targeted osmr signaling by
morpholino injection (Figures S5A–S5D). Compared with
control embryos, osmr morphants exhibited an almost
complete loss of aortic gata2b, runx1, and cmyb at 22 hpf,
28 hpf, and 36 hpf, respectively (Figure 4A). As a conse-
quence, cmyb expression was completely lost in the CHT
at 4 dpf and rag1was either severely reduced or completely
lost at 4.5 dpf (Figures 4B and 4C). Flk1, flt4, and dlc expres-
sion was, however, normal in the aorta in osmrmorphants
at 28 hpf, indicating normal vessel specification (Fig-
ure S6A). Osmr morphants also showed reduced red blood
cell circulation at 48 hpf (n = 16/20, Video S2) compared
with control morphants (n = 10/10, Video S1). This corre-
lated with a small decrease in gata1 expression (Figure S6B)
and a large decrease in o-dianisidine staining at 48 hpf in
osmr morphants (Figure S6C). Furthermore, double trans-
genic flk1:eGFP;gata1:DsRed osmr morphants showed
abnormal tail vasculature and reduced circulating redy Repressing Lymphoid Gene Expression
mus area, where p = 0.0087. Scale, 50 mm.
h arrow indicates a single ikaros:eGFPhigh cell. Scale, 100 mm.
= 0.0028.
0112). Values indicated on FACS plots are mean ± SEM, graphs are
ccr9a (H) (p = 0.1265), and ikaros (I) (p = 0.8030) expression in
ean ± SEM of three data points, calculated from three independent
triplicates, then averaged to give a single value. NI, non-injected
lysis was completed using an unpaired, two-tailed Student’s t test.
AB C
D
Figure 4. osmr Signaling Is Necessary for HSC Specification
(A) gata2b, runx1, and cmyb ISH in control MO, or osmr MO-injected embryos (injected at 4 ng throughout, unless stated). Scale bar,
100 mm. ctl, control.
(B) ISH expression of cmyb, in control MO, or osmr MO-injected embryos. Scale bar, 100 mm.
(C) rag1 expression in the thymus after control MO or osmr MO injection, along with quantification of thymus area. Data are box and
whiskers, min to max. Scale bar, 50 mm.
(D) gata2b, runx1, and cmyb ISH in control MO, or osm MO (injected at 7 ng throughout, unless stated)-injected embryos. Scale bar,
100 mm. Data are boxes and whiskers, min to max. Statistical analysis was completed using an unpaired, two-tailed Student’s t test.
****p < 0.0001.blood cells compared with control embryos at 48 hpf (Fig-
ure S6D). However, primitive myelopoiesis was completely
normal (Figure S6E).We directly targeted osm expression by
morpholino (Figures S5E and S5F) and recapitulated the he-
matopoietic phenotypes observed in osmrmorphants (Fig-
ure 4D). However, we did observe that the majority of osm
morphants display normal cmyb expression at 36 hpf, indi-
cating a recover from the reduction of gata2b/runx1 expres-
sion (Figure 4D). We conclude that osm overexpression is
sufficient to expand HSCs and that osmr signaling is neces-
sary for HSC specification and primitive erythropoiesis, but
not for primitive myelopoiesis. We next examined the
synergistic effects of osm and kitlgb on HSC expansion
and HSC emergence.osm and kitlgb Synergistically Expand HSCs and
Increase HSC Proliferation
Aswe, and others, have found that kita plays amajor role in
pigmentation but not hematopoiesis (Hultman et al., 2007;
Parichy et al., 1999), we investigated any possible synergy
between the kitlgb/kitb and osm/osmr pathways. The injec-
tion of subliminal doses of kitlgb and osm mRNA alone
resulted in no change in runx1 (28 hpf) or cmyb (4 dpf)
expression (Figures 5A–B0). However, injecting both
mRNAs into the same embryo resulted in a strong increase
of cmyb (4 dpf) in the CHT, although runx1was not affected
at 28 hpf (Figures 5A–5B0), which likely resulted from
increased HSC proliferation in the CHT, as measured by
pH3 staining (Figures 5C–5D0). We therefore concludeStem Cell Reports j Vol. 10 j 1920–1934 j June 5, 2018 1927
Figure 5. osm and kitlgb Signal Synergistically to Expand HSCs in the CHT
(A) runx1 ISH at 28 hpf in NI embryos and kitlgb or osm mRNA-injected embryos (injected separately and together) at subliminal doses.
Scale bar, 100 mm.
(B) cmyb ISH at 4 dpf in NI embryos and kitlgb or osmmRNA-injected embryos (injected separately and together) at subliminal doses. Scale
bar, 100 mm.
(B0) cmyb expression analysis. Analysis is Fisher’s exact test. NI versus kitlgb, p = 0.29; NI versus osm, p = 0.48; NI versus kitlgb + osm,
p = 0.0001.
(C) Imaging schematic.
(D) Immunofluorescence for GFP and pH3. Arrows represent double-positive, proliferating cells. Scale, 25 mm.
(D0) Quantification of double-positive cells. (D0) Data are means ± SD and analysis is an ordinary one-way ANOVA with multiple com-
parisons. ANOVA p value = 0.0082. ***p < 0.001; **p < 0.01; NS, p > 0.05.
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Figure 6. Inhibition of osmr and kitb Signaling Synergistically Inhibits HSC Specification
(A) runx1 (28 hpf) ISH following control MO, osmr MO, or kitb MO injection (separately and together) at subliminal doses (half doses). ctl,
control.
(B) cmyb ISH at 4 dpf following control MO, osmr MO, or kitb MO injection (separately and together) at subliminal doses (half doses). (B0)
Quantification of the results observed in panel (B). High cmybsignal (black), medium cmyb signal (grey) and low cmyb signal (white). Analysis
was generated by Fisher’s exact test. NI versus kitb-MO; p = 0.082, NI versus osmr-MO; p = 0.0089, NI versus kitb+osmr-MOs; p = 0.0000009.
(C) Summary. Aortic ECs transition to ‘‘HE/pro HSC’’ by expressing gata2b, a process that requires osm/osmr signaling. HSCs then begin to
bud from the aorta and begin to express runx1 to become ‘‘pre HSCs’’, a process that requires kitlgb/kitb signaling. HSC then become ‘‘HSCs’’
(legend continued on next page)
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that these cytokines act synergistically to expand HSCs
after they arrive in the CHT.
To further examine this synergistic effect, we co-injected
morpholinos against kitb or osmr, at subliminal doses.
Injections of each morpholino alone resulted in normal
runx1 at 28 hpf and cmyb expression at 4 dpf (Fig-
ure 6A–6B0). However, when injected together, a robust
decrease in runx1 at 28 hpf and cmyb at 4 dpf was observed
(Figures 6A and 6B0). Altogether, these experiments show
that both kitb and osmr signaling pathways act together
to specify, and then expand, HSCs in the CHT (Figure 6C).
DISCUSSION
We have investigated kit signaling in zebrafish hematopoi-
esis and shown interesting functional differences between
the kit and kitlg paralogs, despite their relative similarities.
We found that kita/kiltga signaling is important for pigmen-
tation but not for hematopoiesis, concordant with previ-
ous reports (Hultman et al., 2007; Parichy et al., 1999).
Furthermore, kita is expressed in neural crests and sparse
(kita) mutants survive, are healthy, and only have reduced
melanocyte numbers (Parichy et al., 1999).We also showed
that kitlgb/kitb signaling is required for zebrafish hemato-
poiesis. Our data indicate that kitlgb preferentially signals
through kitb, while kitlga signals through kita, but we
cannot exclude any cross-activation of these ligands with
the two receptors, as low levels of kita were detected in
HSCs. A previous report showed that kitlgb is expressed
within the posterior blood island, the tissue that will give
rise to the CHT at 24 hpf (Hultman et al., 2007). As EMPs
are born in this area, we also checked their numbers in
kitb morphants but could not find any difference at
30 hpf (data not shown). However, kitb but not kita mor-
phants showed a strong decrease of runx1 along the aorta.
Work in the mouse embryo has indicated that Kit-L was
required, not for the initial specification of the hemogenic
endothelium into pro-HSCs, but rather for the maturation
andmaintenance of HSCs inmouse AGMcultures (Rybtsov
et al., 2014). Further studies have shown that cells at the
base of aortic HSC clusters are highly proliferative and ex-
press higher levels of c-Kit (Batsivari et al., 2017). As we
found that gata2b is maintained, but runx1 is lost, in kitb
morphants, we conclude that, as in mammals, kitb
signaling is not required for the initial specification of the
hemogenic endothelium but rather for the maturation of
pro-HSCs into runx1/cmyb-positive pre-HSCs, to follow
the mouse nomenclature that has been proposed (Rybtsovand express cmyb. HSCs migrate to the CHT and can either proliferate
by caudal ECs (cECs). Some will differentiate to lymphoid lineages.
lymphoid lineages is inhibited. HSC proliferation is also synergistically
****p < 0.0001; **p < 0.01. All scale bars, 100 mm. HE, hemogenic e
1930 Stem Cell Reports j Vol. 10 j 1920–1934 j June 5, 2018et al., 2014). Moreover, kitb signaling seems to be also
required for HSC expansion at later stages (Figure 6C).
However, as we previously described, the overexpression
of kitlgb by itself cannot expand HSCs in the CHT (Mahony
et al., 2016). Therefore, we started to investigate for poten-
tial cytokines that could act together with kitlgb. As mouse
and human oncostatin M showed promising results (Nish-
ikawa et al., 2001; Oostendorp et al., 2008), we undertook
to find the ortholog of this cytokine in the zebrafish
genome. Based on synteny and sequence similarities, we es-
tablished that si:ch73-47f2.1 was themost likely candidate.
Moreover, our data indicate that targeting si:ch73-47f2.1 by
morpholino induces the exact same phenotypes observed
in osmr morphants. Altogether, our data suggest that
si:ch73-47f2.1 is the zebrafish ortholog of Oncostatin M.
However, we were unable to find orthologs of si:ch73-
47f2.1 in many other closely related fish species (such as
Sinocyclocheilus rhinocerous and medaka), although in
many cases an ortholog for osmr is listed. This, coupled
with the low amino acid similarity, raises the possibility
that si:ch73-47f2.1 could encode a novel, zebrafish-specific
regulator of hematopoiesis that would be related to, but
distinct from, osm. We show that osm is expressed in the
CHT vascular niche under the control of tfec, a transcrip-
tion factor that also controls kitlgb expression (Mahony
et al., 2016). Indeed, osm could rescue the HSC defect
observed in tfec mutants and, in contrast to kitlgb, osm
could increase the number of HSCs in the CHT, but we
did not observe any increase of HSCs in the aorta, as was
observed for mouse AGM-HSCs (Mukouyama et al.,
1998). In the CHT, osm acted by increasing HSC prolifera-
tion, similarly to tfec gain of function, and we observed
that this HSC expansion was accompanied by a reduction
of lymphoid development. Indeed, we show here that
osm downregulates irf4a, a transcription factor required
for lymphopoiesis that also controls ccr9a expression
(Wang et al., 2015). Our results suggest that osm negatively
regulates the expression of several lymphoid genes within
lymphoid-primed progenitors. Our results corroborate a
previous report showing that mouse OSM can inhibit the
differentiation of HSCs toward the lymphoid lineage in
the mouse fetal liver (Kinoshita et al., 2001). However,
this study mainly focused on embryonic B cell lymphopoi-
esis (Kinoshita et al., 2001), whereas our results point to the
effect of osm on T cell commitment. It is possible that osm
mediates a similar effect uponB cell differentiation but, due
to the late emergence of B lymphopoiesis in zebrafish
(around 20 dpf) (Page et al., 2013), we could not test this(prolif.) or differentiate (diff.) in response to cytokines expressed
Proliferation of HSCs is enhanced by osm and differentiation to
enhanced by both kitlgb and osm signaling through their receptors.
ndothelium.
hypothesis in our experiments. Furthermore, Esashi et al.
(2009) described that OSM deficiency led to a decreased
thymic size and the accumulation of apoptotic thymocytes
in the adult mouse. Zebrafish osmmay also be required for
thymic maintenance in a similar manner, as we show that
the deficiency in the osm pathway decreases definitive
hematopoiesis, therefore resulting in a smaller thymus.
We indeed found that osmr signaling is necessary for
early HSC specification, as indicated by the loss of gata2b/
runx1 in osmr morphants. This role of osm might have
been conserved throughout evolution. Indeed, Osm is
expressed in the mouse AGM region, in the genital ridges
and the sub-aortic mesenchyme (Mukouyama et al.,
1998).Moreover,Osmr is highly enriched in ECs and newly
formed hematopoietic progenitors from the human AGM
but downregulated in fetal liver hematopoietic progenitors
(Ng et al., 2016). We therefore conclude that the osm
signaling pathway is important for the emergence of
HSCs (Figure 6C).
Finally, we tested a possible synergistic effect between
both osm/osmr and kitlgb/kitb pathways, as it was previ-
ously demonstrated in the expansion of human HSCs
(Oostendorp et al., 2008). We first showed that subliminal
inhibition of both osmr and kitb receptors leads to a com-
plete loss of HSC specification, whereas each morpholino
on its own had no effect on HSC specification. As we
show that the block induced in osmr morphants occurs
at an earlier stage than the one induced by the kitb
morpholino, we conclude that both signals are required
sequentially for normal HSC specification. Concerning
HSC expansion in the CHT, we have shown that osm
and kitlgb overexpression is sufficient to expand hemato-
poiesis in vivo, which corroborates results gained from
in vitro analysis on human HSCs (Oostendorp et al.,
2008). Altogether, our data convincingly show that the
kit pathway has been conserved in the zebrafish model
to allow normal HSC development. Moreover, we show
that it acts together with the osm/osmr pathway during
HSC specification from the hemogenic endothelium and
for the expansion phase in the CHT. Moreover, by modu-
lating these two pathways, we could unravel discrete
stages of HSC specification from the hemogenic endothe-
lium. Further studies will be required to fully understand
the precise sequence of events, as well as the source of the
signals.EXPERIMENTAL PROCEDURES
Zebrafish Strains and Husbandry
AB* (WT), alongwith transgenic andmutant strains, were kept in a
14/10 hr light/dark cycle at 28C (Westerfield, 1994). We used the
following transgenic animals: lmo2:eGFPzf71 (Zhu et al., 2005),
gata1:DsRedsd2 (Traver et al., 2003), flk1:eGFPs843 (Jin et al., 2005),flk1:Hsa.HRAS-mCherrys896 (Chi et al., 2008), cmyb:GFPzf169 (North
et al., 2007), ikaros:eGFPfr101 (Hess and Boehm, 2012), tfecug103
mutants (Mahony et al., 2016).Whole-Mount In Situ Hybridization Staining and
Analysis
Whole-mount in situ hybridization (WISH) was performed on 4%
paraformaldehyde (PFA)-fixed embryos at the developmental
time points indicated. Digoxygenin labeled probes were synthe-
sized using an RNA labeling kit (SP6/T7; Roche). RNA probes
were generated by linearization of TOPO-TA or ZeroBlunt vectors
(Invitrogen) containing the PCR-amplified cDNA sequence.
WISH was performed as previously described (Thisse et al.,
1993). Phenotypes were scored by comparing expression with
siblings. All injections were repeated three independent times.
Analysis was performed using GraphPad Prism software. Embryos
were imaged in 100% glycerol using an Olympus MVX10 micro-
scope. Oligonucleotide primers used for the production of ISH
probes are listed in Table S1.O-Dianisidine Staining
Embryos at 48 hpf were stained in 0.9 mg/mL o-dianisidine
(Sigma), 10 mM sodium acetate (pH 4.5), 0.65% hydrogen
peroxide, 60% ethanol for 25 min in the dark, and then fixed in
4% PFA for 1 hr at 4C and imaged in 70% glycerol.Cell Sorting and Flow Cytometry
Zebrafish transgenic embryos (15–20 per biological replicate) were
incubated in 0.5 mg/mL Liberase (Roche) solution and shaken for
90min at 33C, then dissociated, filtered, and resuspended in 0.93
PBS and 1% FCS. Dead cells were labeled and excluded by staining
with 5 nM SYTOX red (Life Technologies) or 300 nM DRAQ7
(Biostatus). Cell sorting was performed using an Aria II (BD Biosci-
ences) or a Bio-Rad S3. Data were analyzed using FlowJo and
statistical analysis completed using Microsoft Excel or GraphPad
Prism.Real-Time qPCR and qPCR Analysis
RNAwas extracted using an RNeasy minikit (QIAGEN) and reverse
transcribed into cDNA using a Superscript III kit (Invitrogen) or
qScript (Quanta Biosciences). qPCR was performed using KAPA
SYBR FAST Universal qPCR Kit (Kapa Biosystems) and run on a
CFX Connect real-time system (Bio-Rad). All primers are listed in
Table S2. Analysis was performed using Microsoft Excel or Prism.Synthesis of Full-Length mRNA and Microinjection
PCR primers to amplify cDNA of interest are listed in Table S1. Tfec
mRNAwas synthesized and injected as previously described (Mah-
ony et al., 2016). mRNA was reverse transcribed using mMessage
mMachine kit SP6 (Ambion) from a linearized pCS2+ vector con-
taining PCR products. Following transcription, RNA was purified
by phenol-chloroform extraction. osm mRNA was injected at 300
pg, unless otherwise stated.Stem Cell Reports j Vol. 10 j 1920–1934 j June 5, 2018 1931
Imaging
WISH was imaged using an Olympus MVX10microscope in 100%
glycerol. Fluorescent images were taken with an Olympus IX83
microscope and processed using cellSens Dimension software. All
images were processed using Adobe Photoshop.Immunofluorescence Staining
Images were obtained with a Nikon SMZ1500 microscope or a Ni-
kon inverted A1r spectral confocal microscope. Z stacks were
made through the entire CHT during confocal imaging
in multiple fluorescent channels. Immunofluorescence double
staining was carried out and analyzed as described previously
(Gao et al., 2015), with chicken anti-GFP (1:400, Life Technolo-
gies, catalog no. A10262) and rabbit anti-phospho-histone 3 (pH3)
antibodies (1:250, abcam, catalog no. ab5176). AlexaFluor488-
conjugated anti-chicken secondary antibody (1:1,000, Life
Technologies, catalog no A11039) and AlexaFluor594-con-
jugated anti-rabbit secondary antibody (1:1,000, Life Tech-
nologies, catalog no. A11012) were used to reveal primary
antibodies.Morpholinos
Allmorpholino oligonucleotides (MOs)were purchased fromGene
Tools and are listed in Table S3. MO efficiency was tested using
qPCR from total RNA extracted from 10 embryos at 24 hpf. qPCR
primers are listed in Table S2. osmr, kita, and kitb morpholinos
were injected at 4 ng, 3 ng, and 8 ng, respectively, unless otherwise
stated. Kitlgb and osmMOs were injected at 5 ng and 7 ng, respec-
tively, unless otherwise stated. Kitlgb MO efficiency was tested
using full-length primers (Table S1). OsmMO efficiency was tested
using qPCR primers (Table S2). AllMOs used in this study are splice
blocking MOs.
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